Literature DB >> 1659616

Central motor conduction studies in hereditary spastic paraplegia.

W Schady1, J P Dick, A Sheard, S Crampton.   

Abstract

Central motor conduction (CMC) studies were carried out in 25 patients with hereditary spastic paraplegia (HSP). Responses evoked in the lower limbs by transcranial magnetic stimulation of the motor cortex were bilaterally absent in 33% of the patients and, when recordable, were delayed in 75% of cases. Responses in the upper limbs were mostly normal except for those from the five members of one family, which were considerably delayed. There was no correlation between CMC parameters and age, duration of disease or upper limb hyperreflexia. CMC time to the tibialis anterior correlated with disability in patients with juvenile-onset HSP. It is concluded that CMC studies are not useful in detecting subclinical lesions in hereditary spastic paraplegia but may be of value in identifying subgroups of the disease.

Entities:  

Mesh:

Year:  1991        PMID: 1659616      PMCID: PMC1014514          DOI: 10.1136/jnnp.54.9.775

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Hereditary (familial) spastic paraplegia; further clinical and pathologic observations.

Authors:  G A SCHWARZ; C N LIU
Journal:  AMA Arch Neurol Psychiatry       Date:  1956-02

2.  Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  P D Donofrio; R Tandan; J W Albers
Journal:  Muscle Nerve       Date:  1985-05       Impact factor: 3.217

3.  Electrical stimulation over the human vertebral column: which neural elements are excited?

Authors:  K R Mills; N M Murray
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1986-06

4.  The interpretation of electromyographic responses to electrical stimulation of the motor cortex in diseases of the upper motor neurone.

Authors:  P D Thompson; B L Day; J C Rothwell; J P Dick; J M Cowan; P Asselman; G B Griffin; M P Sheehy; C D Marsden
Journal:  J Neurol Sci       Date:  1987-08       Impact factor: 3.181

5.  F-wave velocity in the central segment of the median and ulnar nerves. A study in normal subjects and in patients with Charcot-Marie-Tooth disease.

Authors:  J Kimura
Journal:  Neurology       Date:  1974-06       Impact factor: 9.910

6.  Measurement of central motor conduction in multiple sclerosis by magnetic brain stimulation.

Authors:  C W Hess; K R Mills; N M Murray
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

7.  Non-invasive magnetic stimulation of human motor cortex.

Authors:  A T Barker; R Jalinous; I L Freeston
Journal:  Lancet       Date:  1985-05-11       Impact factor: 79.321

8.  Central motor conduction in degenerative ataxic disorders: a magnetic stimulation study.

Authors:  D Claus; A E Harding; C W Hess; K R Mills; N M Murray; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

9.  Electrophysiologic evaluation of spinal cord motor conduction.

Authors:  A R Berger; B T Shahani
Journal:  Muscle Nerve       Date:  1989-12       Impact factor: 3.217

10.  Central motor conduction in multiple sclerosis: evaluation of abnormalities revealed by transcutaneous magnetic stimulation of the brain.

Authors:  D A Ingram; A J Thompson; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

View more
  12 in total

Review 1.  Hereditary spastic paraparesis: a review of new developments.

Authors:  C McDermott; K White; K Bushby; P Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

2.  Autosomal dominant pure spastic paraplegia: a clinical, paraclinical, and genetic study.

Authors:  J E Nielsen; K Krabbe; P Jennum; P Koefoed; L N Jensen; K Fenger; H Eiberg; L Hasholt; L Werdelin; S A Sørensen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

3.  Superconditioning TMS for examining upper motor neuron function in MND.

Authors:  Blair Calancie; Eufrosina Young; Mary Lou Watson; Dongliang Wang; Natalia Alexeeva
Journal:  Exp Brain Res       Date:  2019-06-07       Impact factor: 1.972

Review 4.  Sensory neuropathy in hereditary spastic paraplegia.

Authors:  W Schady; C M Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

5.  Posterior tibial nerve somatosensory evoked potentials in slowly progressive spastic paraplegia: a comparative study with clinical signs.

Authors:  C M Aalfs; J H Koelman; M Aramideh; L J Bour; R P Bruyn; B W Ongerboer de Visser
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

6.  Motor system abnormalities in hereditary spastic paraparesis type 4 (SPG4) depend on the type of mutation in the spastin gene.

Authors:  D Bönsch; A Schwindt; P Navratil; D Palm; C Neumann; S Klimpe; J Schickel; J Hazan; C Weiller; T Deufel; J Liepert
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

7.  Altered cortical inhibitory function in children with spastic diplegia: a TMS study.

Authors:  Julia Vry; Michaela Linder-Lucht; Steffen Berweck; Ulrike Bonati; Maike Hodapp; Markus Uhl; Michael Faist; Volker Mall
Journal:  Exp Brain Res       Date:  2008-01-23       Impact factor: 1.972

8.  Hereditary "pure" spastic paraplegia: a study of nine families.

Authors:  J M Polo; J Calleja; O Combarros; J Berciano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

9.  Electrophysiological characterisation of motor and sensory tracts in patients with hereditary spastic paraplegia (HSP).

Authors:  Kathrin N Karle; Rebecca Schüle; Stephan Klebe; Susanne Otto; Christian Frischholz; Inga Liepelt-Scarfone; Ludger Schöls
Journal:  Orphanet J Rare Dis       Date:  2013-10-09       Impact factor: 4.123

10.  Enhanced reticulospinal output in patients with (REEP1) hereditary spastic paraplegia type 31.

Authors:  K M Fisher; P F Chinnery; S N Baker; M R Baker
Journal:  J Neurol       Date:  2013-11-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.